Body cavities of the trunk-pleural and pericardial, percutaneous approach
85811500
Category
Body cavities of the trunk-pleural and pericardial, percutaneous approach is an EFRIS commodity class (code 85811500) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.
30 items in this category
- Exempt
85811503Introduction of analgesics, hypnotics, sedatives into pericardial cavity, percutaneous approach - Exempt
85811518Introduction of analgesics, hypnotics, sedatives into pleural cavity, percutaneous approach - Exempt
85811510Introduction of anti-inflammatory into pericardial cavity, percutaneous approach - Exempt
85811525Introduction of anti-inflammatory into pleural cavity, percutaneous approach - Exempt
85811501Introduction of destructive agent into pericardial cavity, percutaneous approach - Exempt
85811516Introduction of destructive agent into pleural cavity, percutaneous approach - Exempt
85811508Introduction of electrolytic and water balance substance into pericardial cavity, percutaneous approach - Exempt
85811523Introduction of electrolytic and water balance substance into pleural cavity, percutaneous approach - Exempt
85811515Introduction of liquid brachytherapy radioisotope into pericardial cavity, percutaneous approach - Exempt
85811530Introduction of liquid brachytherapy radioisotope into pleural cavity, percutaneous approach - Exempt
85811507Introduction of local anesthetic into pericardial cavity, percutaneous approach - Exempt
85811522Introduction of local anesthetic into pleural cavity, percutaneous approach - Exempt
85811513Introduction of monoclonal antibody into pericardial cavity, percutaneous approach - Exempt
85811528Introduction of monoclonal antibody into pleural cavity, percutaneous approach - Exempt
85811509Introduction of nutritional substance into pericardial cavity, percutaneous approach - Exempt
85811524Introduction of nutritional substance into pleural cavity, percutaneous approach - Exempt
85811511Introduction of other anti-infective into pericardial cavity, percutaneous approach - Exempt
85811526Introduction of other anti-infective into pleural cavity, percutaneous approach - Exempt
85811514Introduction of other antineoplastic into pericardial cavity, percutaneous approach - Exempt
85811529Introduction of other antineoplastic into pleural cavity, percutaneous approach - Exempt
85811504Introduction of other diagnostic substance into pericardial cavity, percutaneous approach - Exempt
85811519Introduction of other diagnostic substance into pleural cavity, percutaneous approach - Exempt
85811502Introduction of other gas into pericardial cavity, percutaneous approach - Exempt
85811517Introduction of other gas into pleural cavity, percutaneous approach - Exempt
85811506Introduction of other therapeutic substance into pericardial cavity, percutaneous approach - Exempt
85811521Introduction of other therapeutic substance into pleural cavity, percutaneous approach - Exempt
85811512Introduction of oxazolidinones into pericardial cavity, percutaneous approach - Exempt
85811527Introduction of oxazolidinones into pleural cavity, percutaneous approach - Exempt
85811505Introduction of radioactive substance into pericardial cavity, percutaneous approach - Exempt
85811520Introduction of radioactive substance into pleural cavity, percutaneous approach